Articles Equine

30 July 2026

Ultraviolet C (UV-C) Light Therapy Inhibits Pathogens Associated With Equine Keratomycosis at Different Corneal Depths-An Ex Vivo Study.

Clinical evidence update from Veterinary ophthalmology

Clinical Context

Peer-reviewed veterinary literature continues to shape everyday decision-making for production animal practice, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.

What the Study Evaluated

A study published in Veterinary ophthalmology in 2026 evaluated ultraviolet C (UV-C) Light Therapy Inhibits Pathogens Associated With Equine Keratomycosis at Different Corneal Depths-An Ex Vivo Study..

Key Findings

To assess if an inexpensive, commercially available ultraviolet C (UV-C) light device with a peak emission of 275 nm can inhibit equine keratomycosis-associated pathogens located at different corneal depths in an ex vivo model. A controlled, randomized experimental design. Aspergillus fumigatus and Fusarium solani isolates were inoculated in fresh bovine corneoscleral transplants, superficially or at 450 μm of stromal depth for the ulcerative keratomycosis or stromal abscess model, respectively. After a minimum of 18 h of incubation, treatment groups received 15 s of UV-C light exposure at a 10 mm distance from the corneal surface level...

Why It Matters for Veterinary Professionals

For veterinary professionals, the practical value of this work lies in how the findings may support more structured clinical assessment, clearer monitoring, and more informed decisions for production animal practice.

Practical Interpretation

The results should be interpreted in the context of the study design, population, inclusion criteria, and clinical setting. Application in practice should consider patient-specific risk factors, available diagnostics, local standards of care, and clinician judgment.

Clinical Takeaway

Overall, the study adds useful evidence for clinicians seeking to align daily practice with current veterinary research while maintaining a balanced, case-by-case approach.

Read the full article here.

Like0

Dislike0

List
Add

Please enter a comment

Name *

Email address *

Comment *

* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.

I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies

Dislike0

News of interest

Multilevel analysis of risk factors for clinical mastitis in dairy cows in Plateau State, Nigeria a hierarchical mixed-effects logistic regression modelling approach.

Strategies for Reducing Antimicrobial Use in Cattle Through Gut Microbiome Modulation A Systematic Review of Alternatives to Antibiotics.

Long term safety and efficacy of a functionalized nanogel with endothelin-1 and bradykinin receptor antagonist peptides for treatment of osteoarthritis of the metacarpophalangeal and distal interphalangeal joints in horses

Exploration of the efficacy of eucalyptus oil (micro-capsules) and mangosteen extract against Eimeria tenella infection in chickens.

EVENTS

Edrapublishing

About Us Authors Contact Us Legal Notes Privacy Search

Top

Ultraviolet C (UV-C) Light Therapy Inhibits Pathogens Associated With Equine Keratomycosis at Different Corneal Depths-An Ex Vivo Study.

Clinical evidence update from Veterinary ophthalmology

Comments

List

Add

Tag

Related Articles

30 July 2026
Valvular mitral stenosis in adult cats knowledge gained from the clinical and pathological workup of 18 cases.

Valvular mitral stenosis in adult cats knowledge gained from the clinical and pathological workup of 18 cases.

30 July 2026
Risk Factors Associated with Azotemia in Dogs Presented to the Chiang Mai University Veterinary Teaching Hospital, Thailand A Retrospective Study (2017-2021).

Risk Factors Associated with Azotemia in Dogs Presented to the Chiang Mai University Veterinary Teaching Hospital, Thailand A Retrospective Study (2017-2021).

29 July 2026
Cervical ventroflexion in cats 86 cases (2003-2024).

Cervical ventroflexion in cats 86 cases (2003-2024).

29 July 2026
No light, no problem provision of light during simulated transport does not alter broiler chick performance or welfare outcomes.

No light, no problem provision of light during simulated transport does not alter broiler chick performance or welfare outcomes.

29 July 2026
Prognostic Markers Associated with Short-Term Mortality in Dogs Hospitalised with Acute Pancreatitis A Retrospective Study of 192 Cases.

Prognostic Markers Associated with Short-Term Mortality in Dogs Hospitalised with Acute Pancreatitis A Retrospective Study of 192 Cases.

More news